ATE451445T1 - Verfahren und vorrichtungen zur entfernung von psoralenen aus blutprodukten. - Google Patents

Verfahren und vorrichtungen zur entfernung von psoralenen aus blutprodukten.

Info

Publication number
ATE451445T1
ATE451445T1 AT96921456T AT96921456T ATE451445T1 AT E451445 T1 ATE451445 T1 AT E451445T1 AT 96921456 T AT96921456 T AT 96921456T AT 96921456 T AT96921456 T AT 96921456T AT E451445 T1 ATE451445 T1 AT E451445T1
Authority
AT
Austria
Prior art keywords
devices
removal
blood products
methods
psoralen
Prior art date
Application number
AT96921456T
Other languages
English (en)
Inventor
Derek Hei
Original Assignee
Cerus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerus Corp filed Critical Cerus Corp
Priority claimed from US08/659,249 external-priority patent/US6544727B1/en
Application granted granted Critical
Publication of ATE451445T1 publication Critical patent/ATE451445T1/de

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00Layered products comprising a layer of synthetic resin
    • B32B27/12Layered products comprising a layer of synthetic resin next to a fibrous or filamentary layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/19Platelets; Megacaryocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08Radiation
    • A61L2/081Gamma radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A61M1/3686Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents by removing photoactive agents after irradiation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00Layered products comprising a layer of synthetic resin
    • B32B27/36Layered products comprising a layer of synthetic resin comprising polyesters
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/02Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer
    • B32B5/028Net structure, e.g. spaced apart filaments bonded at the crossing points
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05Living organisms or biological materials
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2367/00Polyesters, e.g. PET, i.e. polyethylene terephthalate
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2439/00Containers; Receptacles
    • B32B2439/80Medical packaging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • External Artificial Organs (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT96921456T 1995-06-07 1996-06-07 Verfahren und vorrichtungen zur entfernung von psoralenen aus blutprodukten. ATE451445T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48492695A 1995-06-07 1995-06-07
US66091096A 1996-06-07 1996-06-07
US08/659,249 US6544727B1 (en) 1995-06-07 1996-06-07 Methods and devices for the removal of psoralens from blood products
PCT/US1996/009846 WO1996040857A1 (en) 1995-06-07 1996-06-07 Methods and devices for the removal of psoralens from blood products

Publications (1)

Publication Number Publication Date
ATE451445T1 true ATE451445T1 (de) 2009-12-15

Family

ID=29740870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921456T ATE451445T1 (de) 1995-06-07 1996-06-07 Verfahren und vorrichtungen zur entfernung von psoralenen aus blutprodukten.

Country Status (8)

Country Link
EP (1) EP0840781B1 (de)
JP (1) JP4968974B2 (de)
AT (1) ATE451445T1 (de)
AU (1) AU6267796A (de)
CA (1) CA2221605C (de)
DE (1) DE69638094D1 (de)
ES (1) ES2337852T3 (de)
WO (1) WO1996040857A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009051846A (ja) * 1995-06-07 2009-03-12 Cerus Corp 血液製剤からソラレンを除去するための方法およびデバイス
CA2199731A1 (en) * 1995-06-07 1996-12-19 Susan Wollowitz Treating red blood cell solutions with anti-viral agents
DE19544297A1 (de) * 1995-11-28 1997-06-05 Behringwerke Ag Verfahren zur Entfernung von aromatischen Verbindungen aus produkthaltigen Lösungen
CA2251624C (en) * 1996-04-09 2010-06-08 Therakos, Inc. Method for removal of psoralens from biological fluids
DE69827770T2 (de) * 1997-01-06 2006-03-02 Cerus Corp., Concord Adsorbentien und geräte zur verminderung von kleinen organischen verbindungen aus blutprodukten
US6514987B1 (en) 1997-01-06 2003-02-04 Cerus Corporation Frangible compounds for pathogen inactivation
US20010009756A1 (en) 1998-01-06 2001-07-26 Derek Hei Flow devices for the reduction of compounds from biological compositions and methods of use
US6093725A (en) * 1997-01-06 2000-07-25 Cerus Corporation Frangible compounds for pathogen inactivation
US20010018179A1 (en) 1998-01-06 2001-08-30 Derek J. Hei Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
US7611831B2 (en) 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
CN1203900C (zh) 1998-01-06 2005-06-01 塞鲁斯公司 用于淬灭生物材料中病原体灭活剂的方法
US6617100B2 (en) * 1998-09-25 2003-09-09 V.I. Technologies, Inc. Solid phase quenching systems
US6403359B1 (en) * 1998-09-25 2002-06-11 V. I. TECHNOLOGIES, Inc. Solid phase quenching systems
US7068361B2 (en) 1999-06-03 2006-06-27 Baxter International Apparatus, systems and methods for processing and treating a biological fluid with light
US6565802B1 (en) 1999-06-03 2003-05-20 Baxter International Inc. Apparatus, systems and methods for processing and treating a biological fluid with light
US7445756B2 (en) * 1999-06-03 2008-11-04 Fenwal, Inc. Fluid processing sets and organizers for the same
US6364864B1 (en) 1999-06-03 2002-04-02 Baxter International Inc. Plastic containers having inner pouches and methods for making such containers
US7025877B1 (en) * 1999-06-03 2006-04-11 Baxter International Inc. Processing set for processing and treating a biological fluid
JP5112060B2 (ja) * 2004-06-29 2013-01-09 リライアンス ライフ サイエンシーズ プライベイト リミテッド ウイルス安全性生物学的流体の調製のための方法
EP1838355B1 (de) 2004-10-29 2013-08-14 Cerus Corporation Verbesserte quench-verfahren für ein erythrozyten-inaktivierungsverfahren
MX2008007716A (es) 2005-12-13 2008-09-26 Exthera Ab Metodo para eliminar extra corporalmente de la sangre un microbio patogeno, una celula inflamatoria o una proteina inflamatoria.
US7802796B2 (en) 2006-01-05 2010-09-28 Saint-Gobain Performance Plastics Corporation Composite material and seals formed thereof
WO2007082111A1 (en) 2006-01-05 2007-07-19 Saint-Gobain Performance Plastics Corporation Annular seal and pump including same
CA2720824C (en) 2008-04-09 2021-09-14 Cerus Corporation Improved quenching methods for red blood cell pathogen inactivation
DE202008012267U1 (de) * 2008-09-16 2009-02-05 KBD Gesellschaft für Unternehmensberatung, Marketing und Vertrieb mbH i. Gr. Vorrichtung zum visuellen Erkennen der Verteilung von lumineszierenden Substanzen
US8686175B2 (en) 2008-12-16 2014-04-01 Dow Corning Corporation Preparation of siloxanes
US8349959B2 (en) 2008-12-24 2013-01-08 Saint-Gobain Performance Plastics Corporation Polymer material and seals formed thereof for high pressure pump applications
WO2011049709A1 (en) 2009-10-23 2011-04-28 Fenwal, Inc. Methods and systems for providing red blood cell products with reduced plasma
CN106178161B (zh) 2009-12-01 2020-12-22 艾克塞拉医疗公司 使用固定于表面的多糖从血液中去除细胞因子的方法
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
WO2013188073A1 (en) 2012-06-13 2013-12-19 Exthera Medical, Llc Use of heparin and carbohydrates to treat cancer
US9295393B2 (en) 2012-11-09 2016-03-29 Elwha Llc Embolism deflector
US20140158604A1 (en) * 2012-12-12 2014-06-12 Jacques Chammas Platelet Storage Container
BR112015032134B1 (pt) 2013-06-24 2022-05-10 Exthera Medical Corporation Método de ligação em ponto de extremidade de uma manose não redutora a um substrato e esfera possuindo uma manose ligada em ponto de extremidade
CN105339388B (zh) 2013-07-12 2021-06-15 Emd密理博公司 确定利用活性炭从包含靶蛋白的样品去除病毒的方法
EP3065796B1 (de) 2013-11-08 2020-04-15 ExThera Medical Corporation Verfahren zur diagnose von infektionskrankheiten unter verwendung von adsorptionsmedien
DE15782250T1 (de) 2014-04-24 2017-08-10 Exthera Medical Corporation Verfahren zur Entfernung von Bakterien aus Blut unter Verwendung einer hohen Durchflussrate
EA201790265A1 (ru) 2014-07-23 2017-07-31 Сирус Корпорейшн Способы получения тромбоцит-содержащих продуктов
KR20170060062A (ko) * 2014-09-22 2017-05-31 엑스테라 메디컬 코퍼레이션 웨어러블 혈액관류 장치
US20170304363A1 (en) 2014-10-10 2017-10-26 Cerus Corporation Compositions and methods for treating viral hemorrhagic fever
CA2990864A1 (en) 2015-06-26 2016-12-29 Cerus Corporation Cryoprecipitate compositions and methods of preparation thereof
US20170028121A1 (en) * 2015-07-31 2017-02-02 Fenwal, Inc. Irradiation device for biological fluids
WO2017070619A1 (en) 2015-10-23 2017-04-27 Cerus Corporation Plasma compositions and methods of use thereof
US20200078406A1 (en) 2016-01-07 2020-03-12 Cerus Corporation Systems and methods for preparation of platelets
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
CA3055203A1 (en) 2017-03-03 2018-09-07 Cerus Corporation Kits and methods for preparing pathogen-inactivated platelet compositions
EP3684774A1 (de) 2017-09-20 2020-07-29 Cerus Corporation Zusammensetzungen und verfahren zur pathogeninaktivierung von blutplättchen
WO2019133929A1 (en) 2017-12-29 2019-07-04 Cerus Corporation Systems and methods for treating biological fluids
BR112021021141A2 (pt) 2019-05-16 2021-12-14 Exthera Medical Corp Método para modular estrutura glicocalyx endotelial
WO2020263759A2 (en) 2019-06-22 2020-12-30 Cerus Corporation Biological fluid treatment systems
US12514944B2 (en) 2019-06-22 2026-01-06 Cerus Corporation Systems and methods for implementing treatment of biological fluids
AU2020308035B2 (en) 2019-06-28 2025-07-24 Cerus Corporation System and methods for implementing a biological fluid treatment device
US20260034277A1 (en) 2024-06-20 2026-02-05 Cerus Corporation Systems and methods for pathogen inactivation of blood products

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756082A (fr) * 1969-09-12 1971-03-11 I Elementoorganiche Kih Soedin Squelettes macroreticulaires de polystyrene pour resines echangeuses d'ions et leur procede de preparation (
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
DE3819000A1 (de) * 1988-06-03 1989-12-14 Hasso Von Bluecher Beutel in der art eines teebeutels zur beseitigung von schadstoffen
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5418130A (en) * 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5176634A (en) * 1990-08-02 1993-01-05 Mcgaw, Inc. Flexible multiple compartment drug container
US5209347A (en) * 1990-12-05 1993-05-11 Clintec Nutrition Company Internal tear seal dual bag
US5128048A (en) * 1991-05-22 1992-07-07 Baxter International Inc. Systems and methods for removing undesired matter from blood cells
KR960703167A (ko) * 1993-06-23 1996-06-19 존 더블유. 아담슨 혈액내 바이러스 불활성화 시스템(system for viral inactivation of blood)
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US6319662B1 (en) * 1993-12-17 2001-11-20 Baxter International Inc. Method and apparatus for removing viral contaminants from a body fluid

Also Published As

Publication number Publication date
AU6267796A (en) 1996-12-30
EP0840781A1 (de) 1998-05-13
CA2221605C (en) 2005-10-18
CA2221605A1 (en) 1996-12-19
DE69638094D1 (de) 2010-01-21
ES2337852T3 (es) 2010-04-29
EP0840781A4 (de) 2001-03-21
WO1996040857A1 (en) 1996-12-19
EP0840781B1 (de) 2009-12-09
JP4968974B2 (ja) 2012-07-04
JP2002509518A (ja) 2002-03-26

Similar Documents

Publication Publication Date Title
ATE451445T1 (de) Verfahren und vorrichtungen zur entfernung von psoralenen aus blutprodukten.
US5618663A (en) Device for producing a supernatant of activated thrombocytes, method for implementing the device and supernatant obtained
DE3379644D1 (en) Adsorbent and process for preparing the same
DE3580973D1 (de) Geraet zur bestrahlung von blutteilen.
DE59610208D1 (de) Verfahren zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma
ATE361763T1 (de) Vorrichtung zur extrakorporalen blutbehandlung
WO2003049784A3 (en) Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
DE60215014D1 (de) Zentrifuge zur kontinuierlichen Auftrennung von Blut in Komponenten
DE69033564D1 (de) Verfahren und Vorrichtung zur Behandlung von menschlichem Blut für die Transfusion
DE68917306D1 (de) Verfahren und vorrichtung zur autotransfusion von blut.
ATE113468T1 (de) Verfahren zur trennung von teilchen nach grösse.
DE68902698D1 (de) Verfahren zur trennung von blut in blutkomponenten und einheit zur trennung von blutkomponenten.
CA2251624A1 (en) Method for removal of psoralens from biological fluids
AU5596086A (en) Method of inactivating viruses involving adsorption on solid phase
ATE90575T1 (de) Vorrichtung zur plasmaphorese.
ATE228246T1 (de) Vorrichtung und verfahren für die biospezifische entfernung von heparin
DE69309053D1 (de) Vorrichtung zur extrakorporalen trennung von fluorchemikalien
DE69122752D1 (de) Verfahren und Vorrichtung zur Bestimmung der Gerinnungszeit von Blut und Plasma
DE50013540D1 (de) Vorrichtung zur autologenen Transfusion von Blut
DE3855127D1 (de) Methode zur Entfernung von Granulozyten aus dem Blut und Gerät dafür
ATE174624T1 (de) Verfahren zur aktivierung von blutgerinnungsfaktoren
EP0400518A3 (de) Autotransfusionssystem für das Sammeln, die Behandlung und die Rückführung von Blut eines Patienten
DE3678946D1 (de) Verfahren und vorrichtung zur trennung von serum und plasma aus blut.
ATE62999T1 (de) Verfahren und vorrichtung zur trennung von serum und plasma aus blut.
Ryzhko et al. Effectiveness of different methods of blood separation in performing plasma-and cytapheresis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties